The company Amarin, the manufacturer of Vascepa, provides support for its expensive copays through various programs. One such program is the Vascepa Copayment Program, which offers eligible commercially insured patients a $15 copay for a 30-day prescription [1]. According to Amarin's website, this program is designed to help patients cover the out-of-pocket costs associated with Vascepa.
In addition to Amarin's own support program, patient support foundations may provide additional assistance to patients who are struggling to pay for Vascepa due to high copays. However, specific information about these foundations and their eligibility criteria is not readily available. For patients who may be struggling to afford Vascepa, it is recommended that they speak with their healthcare provider or pharmacist about potential options.
As per the website DrugPatentWatch.com, which tracks pharmaceutical patents and pricing, Vascepa's high price is a significant concern for patients and healthcare providers [2].
Sources:
[1] https://www.vascepa.com/copay-assistance
[2] https://www.drugpatentwatch.com/